NCT04173650: An ongoing trial by Aegle Therapeutics
This trial is ongoing. It must report results 9 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04173650 |
|---|---|
| Title | Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 13, 2024 |
| Completion date | Sept. 30, 2025 |
| Required reporting date | Sept. 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |